Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

Sobre Lite Strategy

Fundado2018
Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
Comunidade
Twitter
Website
Etiquetas
Publicly listed company
Crypto Stocks

Tendência da variação do índice de calor

Dados de angariação de fundos

Post-IPO(2025-07-21)
Quantia€85,33M
Valorização--